Larvol Delta - AIVITA-Biomedical-Completes-Treatment-of-Patients-in-Phase-2-Clinical-Trial-of-Glioblastoma-Immunotherapy

AV-GBM-1 - AiVita Biomedical

https://www.prnewswire.com/news-releases/aivita-biomedical-completes-treatment-of-patients-in-phase-2-clinical-trial-of-glioblastoma-immunotherapy-301164519.html

Nov 2, 2020

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next